Yasmin Mahal is a Respiratory physician. OpenAlex indexes 9 publications with 593 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9 Healthcare Dr Ste 209
Biddeford, ME 040059450
Telephone
207-283-6408Registry record last updated 20 Sept 2018.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- United Therapeutics CorporationProgram year20253 payments
- United Therapeutics CorporationProgram year20242 payments
- United Therapeutics CorporationProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
71.7%Corticosteroid38.3%Trelegy Ellipta40%Breo Ellipta30%Symbicort9%Arnuity Ellipta6%Breztri Aerosphere5%Budesonide-Formoterol Fumarate4%Fluticasone Propionate3%Fluticasone-Vilanterol2%Breyna2%Part D<11 patientsbeta2-Adrenergic Agonist20.7%Albuterol Sulfate Hfa86%Ventolin Hfa14%Part D≥139 patients+ 6 more classes in this area
Metabolism & gastrointestinal
18.5%H2 blocker7.5%Famotidine100%Part D≥50 patientsCorticosteroid7.4%Prednisone100%Part D≥81 patients+ 1 more class in this area
Anti-infectives
5.7%Macrolide Antimicrobial4.1%Azithromycin100%Part D≥49 patientsTetracycline-class Drug0.9%Doxycycline Monohydrate100%Part D≥15 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Quality of life assessments in major depressive disorder: a review of the literature
General Hospital Psychiatry
2004 - S-Adenosyl-L-Methionine (SAMe) as an Adjunct for Resistant Major Depressive Disorder
Journal of Clinical Psychopharmacology
2004 - P.1.128 Depressive symptoms and suicidal ideationamong college students: A study of 752 students in the Boston area
European Neuropsychopharmacology
2004
Similar KOLs
Other experts from the same institution or the same specialty.
Tim Driscoll
The University of Sydney
Francesco Saverio Violante
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
Mark A. Rubin
University of Bern
Marc Humbert
Inserm
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”